Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E L Krivchenia

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Clinics in Perinatology|August 14, 2001
Principles of screeningM I Evans, E L Krivchenia
Fetal Diagnosis and Therapy|February 25, 1998
Urinary beta-core fragment as a predictor of abnormal pregnancy at 4-6 weeks' gestationL Cardwell, C L Kowalczyk, E L Krivchenia, et al.
Fetal Diagnosis and Therapy|July 1, 1996
An automated image analysis method for the measurement of neutrophil alkaline phosphatase in the prenatal screening of Down syndromeT Tafas, H S Cuckle, S Nasr, et al.
Obstetrics and Gynecology|February 1, 1989
Counseling for low maternal serum alpha-fetoprotein should emphasize all chromosome anomalies, not just Down syndromeA Drugan, E Dvorin, F C Koppitch, et al.
American Journal of Medical Genetics|April 15, 2000
Fiscal impact of a potential legislative ban on second trimester elective terminations for prenatally diagnosed abnormalitiesV L Miller, S B Ransom, M A Ayoub, et al.
Fetal Diagnosis and Therapy|September 1, 1995
Impact of abnormal second-trimester maternal serum single, double, and triple screening on patient choices about prenatal diagnosisD L Lowry, S A Campbell, E L Krivchenia, et al.
Fetal Therapy|January 1, 1989
Aneuploidy with neural tube defects: another reason for complete evaluation in patients with suspected ultrasound anomalies or elevated maternal serum alpha-fetoproteinA Drugan, M P Johnson, E Dvorin, et al.
American Journal of Medical Genetics|August 22, 2000
Determinants of parental decisions after the prenatal diagnosis of down syndrome: bringing in contextD W Britt, S T Risinger, V Miller, et al.
Fetal Diagnosis and Therapy|March 18, 2000
Molecular and fetal tissue biopsy capabilities are needed to maximize prenatal diagnosis of junctional epidermolysis bullosa: fetal skin biopsy using a 1-mm microendoscopeD E Seubert, B Feldman, E L Krivchenia, et al.
Prenatal Diagnosis|August 1, 1990
Determinants of parental decisions to abort for chromosome abnormalitiesA Drugan, A Greb, M P Johnson, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Clinics in Perinatology|August 14, 2001
Principles of screeningM I Evans, E L Krivchenia
Fetal Diagnosis and Therapy|February 25, 1998
Urinary beta-core fragment as a predictor of abnormal pregnancy at 4-6 weeks' gestationL Cardwell, C L Kowalczyk, E L Krivchenia, et al.
Fetal Diagnosis and Therapy|July 1, 1996
An automated image analysis method for the measurement of neutrophil alkaline phosphatase in the prenatal screening of Down syndromeT Tafas, H S Cuckle, S Nasr, et al.
Obstetrics and Gynecology|February 1, 1989
Counseling for low maternal serum alpha-fetoprotein should emphasize all chromosome anomalies, not just Down syndromeA Drugan, E Dvorin, F C Koppitch, et al.
American Journal of Medical Genetics|April 15, 2000
Fiscal impact of a potential legislative ban on second trimester elective terminations for prenatally diagnosed abnormalitiesV L Miller, S B Ransom, M A Ayoub, et al.
Fetal Diagnosis and Therapy|September 1, 1995
Impact of abnormal second-trimester maternal serum single, double, and triple screening on patient choices about prenatal diagnosisD L Lowry, S A Campbell, E L Krivchenia, et al.
Fetal Therapy|January 1, 1989
Aneuploidy with neural tube defects: another reason for complete evaluation in patients with suspected ultrasound anomalies or elevated maternal serum alpha-fetoproteinA Drugan, M P Johnson, E Dvorin, et al.
American Journal of Medical Genetics|August 22, 2000
Determinants of parental decisions after the prenatal diagnosis of down syndrome: bringing in contextD W Britt, S T Risinger, V Miller, et al.
Fetal Diagnosis and Therapy|March 18, 2000
Molecular and fetal tissue biopsy capabilities are needed to maximize prenatal diagnosis of junctional epidermolysis bullosa: fetal skin biopsy using a 1-mm microendoscopeD E Seubert, B Feldman, E L Krivchenia, et al.
Prenatal Diagnosis|August 1, 1990
Determinants of parental decisions to abort for chromosome abnormalitiesA Drugan, A Greb, M P Johnson, et al.
Pageof 2